At a glance
ClinicalIndex Comparison RecordN/ACompleted· 10 enrolled
Drug / intervention
Neuronoff BASMATI Injectrodedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Basic Assessment of Safety and Minimally Invasive Stimulation Via Injectrode
In Brief
A clinical study evaluating Neuronoff BASMATI Injectrode for Chronic Lower Limb Pain. Completed, enrolled 10 participants across 1 site.
Detailed Summary
The objectives of this non-significant risk (NSR) study are to evaluate the safety of the short term placement of the Basmati Injectrode for up to 28 days and the efficacy of conducting electrical current to stimulate subcutaneous nerves on the explant date just prior to explant.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Lower Limb Pain
CountriesUnited States
CollaboratorsOhio Pain Clinic
Timeline
N/ACompletedFinished
202120222023202420252026
Enrollment StartDec 2020
First PostedDec 2020
Primary CompletionMay 2021
TodayJul 2026
First PostedDec 17, 2020
Enrollment StartDec 4, 2020
Primary CompletionMay 21, 2021
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 5.5 years ago
Interventions
Neuronoff BASMATI Injectrodedevice
The 28 day temporary placement of a Basmati Injectrode does not result in unexpected levels of inflammation or encapsulation.